Method and compositions for treating chronic inflammatory disorders

Abstract

A method and composition for treating chronic inflammatory disorders comprising a pharmaceutically acceptable carrier suitable for oral administration or injection and containing a therapeutic amount of a complex of dietary supplement ingredients comprising nicotinamide, quercetin, curcumin, EPA, DHA, hesperetin and glychrrhizin.

1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . (canceled) 
     
     
         8 . A composition for treating chronic inflammatory disorders comprising a pharmaceutically acceptable carrier suitable for oral administration or injection containing a therapeutic amount of a complex of dietary supplement ingredients comprising nicotinamide, quercetin, curcumin, EPA, DHA, hesperetin and glycyrrhizin, and wherein the dietary supplement ingredients are present in the carrier in the following concentration ranges set forth in the table below: 
       
         
           
                 
                 
                 
               
                     
                     
                 
                     
                   Ingredient 
                   % By Weight in Oral-Dosage Form 
                 
                     
                     
                 
                     
                   Nicotinamide 
                   20-40 
                 
                     
                   Quercetin 
                   10-15 
                 
                     
                   Curcumin 
                   10-20 
                 
                     
                   EPA 
                   12-26 
                 
                     
                   DHA 
                    4-12 
                 
                     
                   Hesperetin 
                   0.4-1     
                 
                     
                   Glycyrrhizin 
                   1-4 
                 
                     
                     
                 
             
                
                
                
               
               
                
                
                
                
                
                
                
                
               
            
           
         
       
     
     
         9 . (canceled) 
     
     
         10 . The composition of  claim 8 , wherein the ratio of EPA to DHA (EPA/DHA) must be ≧2.5 and ≦3.2 and the ratio of nicotinamide to the combination of quercetin and curcumin must be ≧0.80 and ≦1.50. 
     
     
         11 . The composition of  claim 8 , wherein the carrier is a tablet, capsule, caplet, or solution and suspension, suitable for oral administration. 
     
     
         12 . The composition of  claim 8 , wherein the carrier is a sterile solution or suspension suitable for injection.